| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Veradermics IncMANE | $105.83 | Strong Buy | $160.00 | +51.19% | 15 hours ago | |
Analyst RankingTop 9% #434 out of 5325 analysts Average Return+9.52% Win Rate58%116 out of 201 Risk vs RewardPoor Good Analyst ColorCitigroup's Geoff Meacham raised their price target on Veradermics (NYSE: MANE) by 18.5% from $135 to $160 on 2026/07/17. The analyst maintained their Strong Buy rating on the stock. Meacham attributed their price target hike the Veradermics' Study 207 that evidence "robust" proof of concept in females with mild-to-moderate pattern hair loss. The analyst said they have extended their model to include the female population and now estimate $500M in 2035 peak sales. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||